Bartram J

Behjati S

Bomken S

Collord G

Coorens THH

Engelbert J

Haniffa M

Heidenreich O

Inglott S

Jardine L

Khabirova E

Piapi A

Porter T

Prigmore E

Straathof K

Teichmann SA

Treger TD

Webb S

Williams O

Young MD

\ua9 2022, The Author(s). KMT2A-rearranged infant ALL is an aggressive childhood leukemia with poor prognosis. Here, we investigated the developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia (B-ALL) using bulk messenger RNA (mRNA) meta-analysis and examination of single lymphoblast transcriptomes against a developing bone marrow reference. KMT2A-rearranged infant B-ALL was uniquely dominated by an early lymphocyte precursor (ELP) state, whereas less adverse NUTM1-rearranged infant ALL demonstrated signals of later developing B cells, in line with most other childhood B-ALLs. We compared infant lymphoblasts with ELP cells and revealed that the cancer harbored hybrid myeloid–lymphoid features, including nonphysiological antigen combinations potentially targetable to achieve cancer specificity. We validated surface coexpression of exemplar combinations by flow cytometry. Through analysis of shared mutations in separate leukemias from a child with infant KMT2A-rearranged B-ALL relapsing as AML, we established that KMT2A rearrangement occurred in very early development, before hematopoietic specification, emphasizing that cell of origin cannot be inferred from the transcriptional state

Newcastle University E-Prints

Single-cell transcriptomics reveals a distinct developmental state of <em>KMT2A</em>-rearranged infant B-cell acute lymphoblastic leukemia

Single-cell transcriptomics reveals a distinct developmental state of <em>KMT2A</em>-rearranged infant B-cell acute lymphoblastic leukemia

Abstract

Similar works

Full text

Available Versions

Newcastle University E-Prints